PubMed:7694465
Annnotations
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T1 | 0-107 | Sentence | denotes | Evaluation of plasma insulin-like growth factor-binding protein-3 as a potential predictor of preeclampsia. |
TextSentencer_T2 | 108-118 | Sentence | denotes | OBJECTIVE: |
TextSentencer_T3 | 119-272 | Sentence | denotes | Elevated growth factor activity in women with preeclampsia is caused by an acid- and heat-labile protein complex with a native molecular mass of 150,000. |
TextSentencer_T4 | 273-375 | Sentence | denotes | The major plasma insulin-like growth factor-binding protein-3 has identical molecular characteristics. |
TextSentencer_T5 | 376-648 | Sentence | denotes | We hypothesized that increased endothelial cell release or decreased proteolytic degradation of insulin-like growth factor-binding protein-3 in preeclampsia would result in higher circulating levels of insulin-like growth factors and hence in increased mitogenic activity. |
TextSentencer_T6 | 649-662 | Sentence | denotes | STUDY DESIGN: |
TextSentencer_T7 | 663-919 | Sentence | denotes | Plasma insulin-like growth factor-binding protein-3 concentrations were determined by iodine-125 insulin-like growth factor-II radioligand blots of nonreducing gels in 16 normal and 16 preeclamptic patients collected from a prospective, case-control study. |
TextSentencer_T8 | 920-1051 | Sentence | denotes | Enzyme-linked immunosorbent assays also were performed with a specific anti-insulin-like growth factor-binding protein-3 antiserum. |
TextSentencer_T9 | 1052-1060 | Sentence | denotes | RESULTS: |
TextSentencer_T10 | 1061-1209 | Sentence | denotes | Insulin-like growth factor-binding protein-3 concentrations were not different between women with normal versus preeclamptic pregnancies (p = 0.23). |
TextSentencer_T11 | 1210-1293 | Sentence | denotes | Enzyme-linked immunosorbent assays confirmed these results in a subset of patients. |
TextSentencer_T12 | 1294-1306 | Sentence | denotes | CONCLUSIONS: |
TextSentencer_T13 | 1307-1551 | Sentence | denotes | The findings indicate that insulin-like growth factor-binding protein-3 concentrations do not account for the elevated mitogenic activity observed in plasma from women with preeclampsia and are not a useful screening test for preeclampsia risk. |
T1 | 0-107 | Sentence | denotes | Evaluation of plasma insulin-like growth factor-binding protein-3 as a potential predictor of preeclampsia. |
T2 | 108-118 | Sentence | denotes | OBJECTIVE: |
T3 | 119-272 | Sentence | denotes | Elevated growth factor activity in women with preeclampsia is caused by an acid- and heat-labile protein complex with a native molecular mass of 150,000. |
T4 | 273-375 | Sentence | denotes | The major plasma insulin-like growth factor-binding protein-3 has identical molecular characteristics. |
T5 | 376-648 | Sentence | denotes | We hypothesized that increased endothelial cell release or decreased proteolytic degradation of insulin-like growth factor-binding protein-3 in preeclampsia would result in higher circulating levels of insulin-like growth factors and hence in increased mitogenic activity. |
T6 | 649-662 | Sentence | denotes | STUDY DESIGN: |
T7 | 663-919 | Sentence | denotes | Plasma insulin-like growth factor-binding protein-3 concentrations were determined by iodine-125 insulin-like growth factor-II radioligand blots of nonreducing gels in 16 normal and 16 preeclamptic patients collected from a prospective, case-control study. |
T8 | 920-1051 | Sentence | denotes | Enzyme-linked immunosorbent assays also were performed with a specific anti-insulin-like growth factor-binding protein-3 antiserum. |
T9 | 1052-1060 | Sentence | denotes | RESULTS: |
T10 | 1061-1209 | Sentence | denotes | Insulin-like growth factor-binding protein-3 concentrations were not different between women with normal versus preeclamptic pregnancies (p = 0.23). |
T11 | 1210-1293 | Sentence | denotes | Enzyme-linked immunosorbent assays confirmed these results in a subset of patients. |
T12 | 1294-1306 | Sentence | denotes | CONCLUSIONS: |
T13 | 1307-1551 | Sentence | denotes | The findings indicate that insulin-like growth factor-binding protein-3 concentrations do not account for the elevated mitogenic activity observed in plasma from women with preeclampsia and are not a useful screening test for preeclampsia risk. |
Preeclampsia
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
PD-Preeclampsia-B_T1 | 94-106 | ORPHA:275555 | denotes | preeclampsia |
PD-Preeclampsia-B_T2 | 165-177 | ORPHA:275555 | denotes | preeclampsia |
PD-Preeclampsia-B_T3 | 520-532 | ORPHA:275555 | denotes | preeclampsia |
PD-Preeclampsia-B_T4 | 848-869 | ORPHA:275555 | denotes | preeclamptic patients |
PD-Preeclampsia-B_T5 | 1480-1492 | ORPHA:275555 | denotes | preeclampsia |
PD-Preeclampsia-B_T6 | 1533-1545 | ORPHA:275555 | denotes | preeclampsia |
Preeclampsia-compare
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
PD-Preeclampsia-B_T1 | 94-106 | ORPHA:275555 | denotes | preeclampsia |
PD-Preeclampsia-B_T2 | 165-177 | ORPHA:275555 | denotes | preeclampsia |
PD-Preeclampsia-B_T3 | 520-532 | ORPHA:275555 | denotes | preeclampsia |
PD-Preeclampsia-B_T4 | 848-860 | ORPHA:275555 | denotes | preeclamptic |
PD-Preeclampsia-B_T5 | 1173-1185 | ORPHA:275555 | denotes | preeclamptic |
PD-Preeclampsia-B_T6 | 1480-1492 | ORPHA:275555 | denotes | preeclampsia |
PD-Preeclampsia-B_T7 | 1533-1545 | ORPHA:275555 | denotes | preeclampsia |
preeclampsia_genes
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
PD-PreeclampsiaGenes-B_T1 | 21-28 | HGNC:INS | denotes | insulin |
PD-PreeclampsiaGenes-B_T2 | 290-297 | HGNC:INS | denotes | insulin |
PD-PreeclampsiaGenes-B_T3 | 472-479 | HGNC:INS | denotes | insulin |
PD-PreeclampsiaGenes-B_T4 | 578-585 | HGNC:INS | denotes | insulin |
PD-PreeclampsiaGenes-B_T5 | 670-677 | HGNC:INS | denotes | insulin |
PD-PreeclampsiaGenes-B_T6 | 760-767 | HGNC:INS | denotes | insulin |
PD-PreeclampsiaGenes-B_T7 | 996-1003 | HGNC:INS | denotes | insulin |
PD-PreeclampsiaGenes-B_T8 | 1061-1068 | HGNC:INS | denotes | Insulin |
PD-PreeclampsiaGenes-B_T9 | 1334-1341 | HGNC:INS | denotes | insulin |
PD-PreeclampsiaGenes-B_T10 | 21-47 | HGNC:IGF2 | denotes | insulin-like growth factor |
PD-PreeclampsiaGenes-B_T11 | 290-316 | HGNC:IGF2 | denotes | insulin-like growth factor |
PD-PreeclampsiaGenes-B_T12 | 472-498 | HGNC:IGF2 | denotes | insulin-like growth factor |
PD-PreeclampsiaGenes-B_T13 | 578-605 | HGNC:IGF2 | denotes | insulin-like growth factors |
PD-PreeclampsiaGenes-B_T14 | 670-696 | HGNC:IGF2 | denotes | insulin-like growth factor |
PD-PreeclampsiaGenes-B_T15 | 760-786 | HGNC:IGF2 | denotes | insulin-like growth factor |
PD-PreeclampsiaGenes-B_T16 | 996-1022 | HGNC:IGF2 | denotes | insulin-like growth factor |
PD-PreeclampsiaGenes-B_T17 | 1061-1087 | HGNC:IGF2 | denotes | Insulin-like growth factor |
PD-PreeclampsiaGenes-B_T18 | 1334-1360 | HGNC:IGF2 | denotes | insulin-like growth factor |
PD-PreeclampsiaGenes-B_T19 | 21-47 | HGNC:IGF1 | denotes | insulin-like growth factor |
PD-PreeclampsiaGenes-B_T20 | 290-316 | HGNC:IGF1 | denotes | insulin-like growth factor |
PD-PreeclampsiaGenes-B_T21 | 472-498 | HGNC:IGF1 | denotes | insulin-like growth factor |
PD-PreeclampsiaGenes-B_T22 | 578-605 | HGNC:IGF1 | denotes | insulin-like growth factors |
PD-PreeclampsiaGenes-B_T23 | 670-696 | HGNC:IGF1 | denotes | insulin-like growth factor |
PD-PreeclampsiaGenes-B_T24 | 760-786 | HGNC:IGF1 | denotes | insulin-like growth factor |
PD-PreeclampsiaGenes-B_T25 | 996-1022 | HGNC:IGF1 | denotes | insulin-like growth factor |
PD-PreeclampsiaGenes-B_T26 | 1061-1087 | HGNC:IGF1 | denotes | Insulin-like growth factor |
PD-PreeclampsiaGenes-B_T27 | 1334-1360 | HGNC:IGF1 | denotes | insulin-like growth factor |
PD-PreeclampsiaGenes-B_T28 | 21-63 | HGNC:IGFBP7 | denotes | insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T29 | 290-332 | HGNC:IGFBP7 | denotes | insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T30 | 472-514 | HGNC:IGFBP7 | denotes | insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T31 | 670-712 | HGNC:IGFBP7 | denotes | insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T32 | 996-1038 | HGNC:IGFBP7 | denotes | insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T33 | 1061-1103 | HGNC:IGFBP7 | denotes | Insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T34 | 1334-1376 | HGNC:IGFBP7 | denotes | insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T35 | 21-65 | HGNC:IGFBP3 | denotes | insulin-like growth factor-binding protein-3 |
PD-PreeclampsiaGenes-B_T36 | 290-334 | HGNC:IGFBP3 | denotes | insulin-like growth factor-binding protein-3 |
PD-PreeclampsiaGenes-B_T37 | 472-516 | HGNC:IGFBP3 | denotes | insulin-like growth factor-binding protein-3 |
PD-PreeclampsiaGenes-B_T38 | 670-714 | HGNC:IGFBP3 | denotes | insulin-like growth factor-binding protein-3 |
PD-PreeclampsiaGenes-B_T39 | 996-1040 | HGNC:IGFBP3 | denotes | insulin-like growth factor-binding protein-3 |
PD-PreeclampsiaGenes-B_T40 | 1061-1105 | HGNC:IGFBP3 | denotes | Insulin-like growth factor-binding protein-3 |
PD-PreeclampsiaGenes-B_T41 | 1334-1378 | HGNC:IGFBP3 | denotes | insulin-like growth factor-binding protein-3 |
PD-PreeclampsiaGenes-B_T42 | 21-63 | HGNC:IGFBP2 | denotes | insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T43 | 290-332 | HGNC:IGFBP2 | denotes | insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T44 | 472-514 | HGNC:IGFBP2 | denotes | insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T45 | 670-712 | HGNC:IGFBP2 | denotes | insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T46 | 996-1038 | HGNC:IGFBP2 | denotes | insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T47 | 1061-1103 | HGNC:IGFBP2 | denotes | Insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T48 | 1334-1376 | HGNC:IGFBP2 | denotes | insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T49 | 21-63 | HGNC:IGFBP4 | denotes | insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T50 | 290-332 | HGNC:IGFBP4 | denotes | insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T51 | 472-514 | HGNC:IGFBP4 | denotes | insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T52 | 670-712 | HGNC:IGFBP4 | denotes | insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T53 | 996-1038 | HGNC:IGFBP4 | denotes | insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T54 | 1061-1103 | HGNC:IGFBP4 | denotes | Insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T55 | 1334-1376 | HGNC:IGFBP4 | denotes | insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T56 | 21-63 | HGNC:IGFBP5 | denotes | insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T57 | 290-332 | HGNC:IGFBP5 | denotes | insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T58 | 472-514 | HGNC:IGFBP5 | denotes | insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T59 | 670-712 | HGNC:IGFBP5 | denotes | insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T60 | 996-1038 | HGNC:IGFBP5 | denotes | insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T61 | 1061-1103 | HGNC:IGFBP5 | denotes | Insulin-like growth factor-binding protein |
PD-PreeclampsiaGenes-B_T62 | 1334-1376 | HGNC:IGFBP5 | denotes | insulin-like growth factor-binding protein |